 |
New spondyloarthritis centre planned in UAEGCC and German rheumatologists plan to establish a Spondyloarthritis Center of Excellence in partnership with Abbvie Biopharmaceuticals, a global, research-based biopharmaceutical company. Rheumatologists from around the GCC recen More… |
 |
350 bone, joint experts to meet in Abu DhabiMore than 350 international and regional rheumatology experts will discuss experiences and cutting-edge knowledge in the field of rheumatology and clinical immunology at an upcoming meeting in Abu Dhabi. The third Abu Dhabi Advanc More… |
 |
Daman launches new health support programmesUAE's National Health Insurance Company, Daman has added three new programmes to its health support services. The programmes include support for colorectal and cervical cancers and rheumatoid arthritis, said a statement. More… |
 |
New hi-tech arthritis clinic in BahrainA programme to tackle the need for early diagnosis and management of rheumatoid arthritis has been set up in Bahrain by online medical resource organisation ENHANCE. The ENHANCE Centre of Excellence at the King Hamad University Ho More… |
 |
Roche arthritis drug 'beats top-selling rival'Roche said on Wednesday that a trial had shown its rheumatoid arthritis drug RoActemra was more effective in reducing swelling and tenderness in joints than Abbott Laboratories' top-selling Humira when given as a single treatment. Humira i More… |
 |
Arthritis linked to early ovary removalHaving both ovaries removed before age 45 is strongly associated with low-bone mineral density and arthritis in later years, according to a new study by Johns Hopkins oncologists and epidemiologists. The analysis covered several thousand w More… |
 |
Roche arthritis drug effective as sole therapyRoche's rheumatoid arthritis drug RoActemra helps treat patients with the painful and debilitating disease regardless of whether it is given on its own or in combination with another drug, a late-stage study showed. The news could boost Ro More… |
 |
Novartis drug gives pain relief in gouty arthritisNovartis AG's gout treatment hopeful gives patients better pain relief and significantly cuts the risk of new attacks, two late stage studies showed, giving the drugmaker's pipeline another boost. Ilaris, or ACZ885, is seen as a key drug f More… |
 |
Pfizer arthritis drug meets main goals of trialPfizer said that its experimental rheumatoid arthritis drug met the main goals of a late-stage clinical trial, a welcome boost for the world's largest drugmaker as it seeks new products to offset those that are losing patent protection. Th More… |
 |
Roche presents arthritis reportHoffmann–La Roche, leader in research-focused healthcare, has presented the latest results about systemic juvenile idiopathic arthritis (sJIA) at a rheumatism congress in Beirut. The 2010 European League Against Rheumatism (Eular) congress More… |
